Product
Trifluridine/tipiracil
4 clinical trials
3 indications
Indication
Metastatic Colorectal CancerIndication
Colorectal CancerIndication
Drug TherapyClinical trial
Randomized Double-blind, Placebo-controlled, Multicenter Clinical Study of Nimotuzumab Combined With Trifluridine/Tipiracil in Third-line and Beyond for the Treatment of Metastatic Colorectal CancerStatus: Not yet recruiting, Estimated PCD: 2027-04-01
Clinical trial
Irinotecan in Combination With Trifluridine-tipiracil and Bevacizumab in Pre-treated Metastatic Colorectal CancerStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
An Open-label, Randomised, Phase III Study cOmparing trifLuridine/Tipiracil (S 95005) in Combination With Bevacizumab to Capecitabine in Combination With Bevacizumab in firST-line Treatment of Patients With metastatIC Colorectal Cancer Who Are Not candidatE for Intensive Therapy (SOLSTICE Study)Status: Active (not recruiting), Estimated PCD: 2021-06-29
Clinical trial
Efficacy and Safety of Trifluridine/Tipiracil Combined With Fufuquitinib Versus Trifluridine/Tipiracil and Fufuquitinib for Third-line Treatment of Unresectable Metastatic Colorectal CancerStatus: Recruiting, Estimated PCD: 2026-06-01